Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CVR Medical Corp V.CVM.H

Alternate Symbol(s):  CRRVF

CVR Medical Corp. is a medical technology organization. The Company is focused on the development and advancement of technology at work within the healthcare sector. The Company’s Carotid Stenotic Scan (CSS) is a diagnostic tool designed to detect and determine a level of carotid narrowing for the purpose of identifying patients at risk for Ischemic Stroke. The CSS provides a synergistic tool which complements other stroke screening technology, such as Duplex Doppler ultrasound (DUS), magnetic resonance angiography (MRA), and computed tomography angiography (CTA). The CSS is 100% non-invasive and does not require the use of harmful dyes. It offers its product to patients, payers, and healthcare providers. The CVR device uses only sound wave analysis to detect the presence of arterial stenosis.


TSXV:CVM.H - Post by User

Bullboard Posts
Comment by Nastroon Jun 16, 2020 3:59am
153 Views
Post# 31154388

RE:RE:RE:RE:RE:RE:RE:Volume

RE:RE:RE:RE:RE:RE:RE:VolumeTalking of those with a low IQ, the tech is solid is it?  If you knew the first thing about this you'd know that the primary IP is based on code written by 2 software engineering subcontractors who haven't been paid for their work.  Under the terms of their contract the IP reverts back to them after 6 months.  So not the tech isn't solid.

This company has been utterly mismanaged by Bakema so what do you expect us to be happy about it?  As I said earlier - investors as a rule do not put money into a company to pay off a failed CEO, unless they have a low IQ perhaps and haven't a clue either about the company or what they are doing.  If you knew anything about financial markets you'd know that companies - bad ones, fail to get finance all the time.

You really should stop pretending that your ill informed posts and wholesale lack of knowledge are of interest to the rest of us.  You display a degree of ignorance when you talk about the amount of money 'poured in' to get the financials done.  The whole point is that they haven't been done or at least not yet, they have been delayed twice and the last press release even warned a further CTO was likely from today onwards because of it.  But hey don't let that stop you and your baseless fantasies about Boston Scientific.

Maybe quit yapping and start following this a bit more closely then if you're going to offer us the benefit of your 'wisdom'.  It's not worth listening to trolls with no money invested.
Bullboard Posts